Veru

About:

Veru is a biopharmaceutical company that specializes in developing novel medicines.

Description:

Veru is a biopharmaceutical company that focuses on infectious diseases and oncology. They develop novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers. Their development portfolio includes sabizabulin, enobosarm, zuclomiphene citrate, and more.

Total Funding Amount:

$133M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Miami, Florida, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)verupharma.com

Founders:

Harry Fisch, Mitchell Steiner

Number of Employees:

101-250

Last Funding Date:

2023-12-14

IPO Status:

Public

Industries: